Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

Autor: Qian, Frank, Wang, Shengfeng, Mitchell, Jonathan, McGuffog, Lesley, Barrowdale, Daniel, Leslie, Goska, Oosterwijk, Jan C, Chung, Wendy K, Evans, D Gareth, Engel, Christoph, Kast, Karin, Aalfs, Cora M, Adank, Muriel A, Adlard, Julian, Agnarsson, Bjarni A, Aittomäki, Kristiina, Alducci, Elisa, Andrulis, Irene L, Arun, Banu K, Ausems, Margreet GEM, Azzollini, Jacopo, Barouk-Simonet, Emmanuelle, Barwell, Julian, Belotti, Muriel, Benitez, Javier, Berger, Andreas, Borg, Ake, Bradbury, Angela R, Brunet, Joan, Buys, Saundra S, Caldes, Trinidad, Caligo, Maria A, Campbell, Ian, Caputo, Sandrine M, Chiquette, Jocelyne, Claes, Kathleen BM, Margriet Collée, J, Couch, Fergus J, Coupier, Isabelle, Daly, Mary B, Davidson, Rosemarie, Diez, Orland, Domchek, Susan M, Donaldson, Alan, Dorfling, Cecilia M, Eeles, Ros, Feliubadaló, Lidia, Foretova, Lenka, Fowler, Jeffrey, Friedman, Eitan, Frost, Debra, Ganz, Patricia A, Garber, Judy, Garcia-Barberan, Vanesa, Glendon, Gord, Godwin, Andrew K, Gómez Garcia, Encarna B, Gronwald, Jacek, Hahnen, Eric, Hamann, Ute, Henderson, Alex, Hendricks, Carolyn B, Hopper, John L, Hulick, Peter J, Imyanitov, Evgeny N, Isaacs, Claudine, Izatt, Louise, Izquierdo, Ángel, Jakubowska, Anna, Kaczmarek, Katarzyna, Kang, Eunyoung, Karlan, Beth Y, Kets, Carolien M, Kim, Sung-Won, Kim, Zisun, Kwong, Ava, Laitman, Yael, Lasset, Christine, Hyuk Lee, Min, Won Lee, Jong, Lee, Jihyoun, Lester, Jenny, Lesueur, Fabienne, Loud, Jennifer T, Lubinski, Jan, Mebirouk, Noura, Meijers-Heijboer, Hanne EJ, Meindl, Alfons, Miller, Austin, Montagna, Marco, Mooij, Thea M, Morrison, Patrick J, Mouret-Fourme, Emmanuelle, Nathanson, Katherine L, Neuhausen, Susan L, Nevanlinna, Heli, Niederacher, Dieter, Nielsen, Finn C, Nussbaum, Robert L, Offit, Kenneth

Publikováno v: Journal of the National Cancer Institute, vol 111, iss 4

BackgroundBRCA1/2 mutations confer high lifetime risk of breast cancer, although other factors may modify this risk. Whether height or body mass index (BMI) modifies breast cancer risk in BRCA1/2 mutation carriers remains unclear.MethodsWe used Mende

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::22fa639da0433fa50aa993e7abdb451a
https://escholarship.org/uc/item/8d25027s

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.

Autor: Qian F; Department of Medicine, The University of Chicago, Chicago, IL., Wang S; Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL.; Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China., Mitchell J; Division of Gastroenterology, Department of Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA., McGuffog L; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK., Barrowdale D; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK., Leslie G; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK., Oosterwijk JC; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Chung WK; Departments of Pediatrics and Medicine, Columbia University, New York, NY., Evans DG; Division of Evolution and Genomic Sciences, Genomic Medicine, Manchester Academic Health Sciences Centre, University of Manchester, Central Manchester University Hospitals, NHS Foundation Trust, Manchester, UK., Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.; LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany., Kast K; Department of Gynecology and Obstetrics, Technical University of Dresden, Dresden, Germany.; Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Aalfs CM; Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands.; Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL.; The University of Chicago Pritzker School of Medicine, Chicago, IL., Adank MA; Family Cancer Clinic, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Adlard J; Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK.; Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Agnarsson BA; Department of Pathology, National Institute of Oncology, Budapest, Hungary.; School of Medicine, University of Iceland, Reykjavik, Iceland., Aittomäki K; Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Alducci E; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.; Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada., Arun BK; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Ausems MGEM; Department of Medical Genetics, University Medical Center, Utrecht, the Netherlands., Azzollini J; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy., Barouk-Simonet E; Oncogénétique, Institut Bergonié, Bordeaux, France.; Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, KS., Barwell J; Leicestershire Clinical Genetics Service, University Hospitals of Leicester NHS Trust, Leicester, UK.; Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, CIBERONC, Girona, Spain., Belotti M; Service de Génétique, Institut Curie, Paris, France., Benitez J; Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Center, University of California Los Angeles, CA., Berger A; Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden., Borg A; Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA.; Institute of Genetic Medicine, Centre for Life, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK., Bradbury AR; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Brunet J; Service de Génétique, Institut Curie, Paris, France.; Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain.; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria., Buys SS; Department of Medicine, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT., Caldes T; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, CIBERONC, Madrid, Spain., Caligo MA; Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa, Italy., Campbell I; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Caputo SM; Leicestershire Clinical Genetics Service, University Hospitals of Leicester NHS Trust, Leicester, UK.; Service de Génétique, Institut Curie, Paris, France., Chiquette J; Unité de recherche en santé des populations, Centre des maladies du sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, QC, Canada., Claes KBM; Centre for Medical Genetics, Ghent University, Ghent, Belgium., Margriet Collée J; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Coupier I; Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France., Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA., Davidson R; Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK., Diez O; N.N. Petrov Institute of Oncology, St. Petersburg, Russia., Domchek SM; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Donaldson A; Oncogenetics Group, Clinical and Molecular Genetics Area, Vall d'Hebron Institute of Oncology (VHIO), University Hospital, Vall d'Hebron, Barcelona, Spain (OD); Clinical Genetics Department, St Michael's Hospital, Bristol, UK., Dorfling CM; Department of Genetics, University of Pretoria, Arcadia, South Africa.; City of Hope Clinical Cancer Genetics Community Research Network, Duarte, CA., Eeles R; Ocogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK., Feliubadaló L; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia., Foretova L; Molecular Diagnostic Unit, Hereditary Cancer Program, ICO-IDIBELL (Catalan Institute of Oncology, Bellvitge Biomedical Research Institute), CIBERONC, Barcelona, Spain.; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Fowler J; The Ohio State University, Columbus Cancer Council, Columbus, OH., Friedman E; The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel., Frost D; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK., Ganz PA; Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Center, University of California Los Angeles, CA., Garber J; Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA., Garcia-Barberan V; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, CIBERONC, Madrid, Spain., Glendon G; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada., Godwin AK; Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, KS., Gómez Garcia EB; Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Gronwald J; Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Hahnen E; Centers for Hereditary Breast and Ovarian Cancer, Integrated Oncology and Molecular Medicine, University Hospital of Cologne, Cologne, Germany Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hamann U, Henderson A; Institute of Genetic Medicine, Centre for Life, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK., Hendricks CB; City of Hope Clinical Cancer Genetics Community Research Network, Duarte, CA., Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia., Hulick PJ; Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL.; The University of Chicago Pritzker School of Medicine, Chicago, IL., Imyanitov EN; N.N. Petrov Institute of Oncology, St. Petersburg, Russia., Isaacs C; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI)., Izatt L; Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK., Izquierdo Á; Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, CIBERONC, Girona, Spain., Jakubowska A; Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Kaczmarek K; Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Kang E; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea., Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA., Kets CM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands., Kim SW; Department of Surgery, Daerim Saint Mary's Hospital, Seoul, Korea., Kim Z; Department of Surgery, Soonchunhyang University Hospital Bucheon, Bucheon, Korea., Kwong A; Hong Kong Hereditary Breast Cancer Family Registry, Happy Valley, Hong Kong.; Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong.; Department of Surgery, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong., Laitman Y; The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel., Lasset C; Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France., Hyuk Lee M; Department of Surgery, Soonchunhyang University College of Medicine and Soonchunhyang University Hospital, Seoul, Korea., Won Lee J; Department of Surgery, Ulsan University College of Medicine and Asan Medical Center, Seoul, Korea., Lee J; Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA.; Department of Surgery, Soonchunhyang University College of Medicine and Soonchunhyang University Hospital, Seoul, Korea., Lester J; Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Lesueur F; Genetic Epidemiology of Cancer team, Institut Curie, Paris, France.; U900, INSERM, Paris, France.; PSL University, Paris, France.; Mines ParisTech, Fontainebleau, France., Loud JT; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD., Lubinski J; Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Mebirouk N; Genetic Epidemiology of Cancer team, Institut Curie, Paris, France.; U900, INSERM, Paris, France.; PSL University, Paris, France.; Mines ParisTech, Fontainebleau, France., Meijers-Heijboer HEJ; Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands., Meindl A; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany.; NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY., Miller A; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany., Montagna M; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Mooij TM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Morrison PJ; Centre for Cancer Research and Cell Biology, Queens University Belfast, Belfast, UK., Mouret-Fourme E; Service de Génétique, Institut Curie, Paris, France., Nathanson KL, Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA., Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Niederacher D; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Nielsen FC; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Nussbaum RL; Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, CA., Offit K; Clinical Genetics Research Laboratory, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY.; Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary., Ong KR; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Birmingham, UK., Ottini L; Department of Molecular Medicine, University La Sapienza, Rome, Italy., Park SK; Departments of Preventive Medicine and Biomedical Sciences, and Cancer Research Institute, Seoul National University, Seoul, Korea., Peterlongo P; IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy., Pfeiler G; Department of Urology, Medical University of Vienna, Vienna, Austria., Phelan CM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL., Poppe B; Centre for Medical Genetics, Ghent University, Ghent, Belgium., Pradhan N; Clinical Genetics Research Laboratory, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY., Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy., Ramus SJ; School of Women's and Children's Health, University of New South Wales Sydney, New South Wales, Australia.; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia., Rantala J; Clinical Genetics, Karolinska Institutet, Stockholm, Sweden., Robson M; Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Rodriguez GC; Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL., Schmutzler RK; Centers for Hereditary Breast and Ovarian Cancer, Integrated Oncology and Molecular Medicine, University Hospital of Cologne, Cologne, Germany Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hutten Selkirk CG; Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL., Shah PD; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Simard J; Laboratoire de génétique médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France., Singer CF; Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Sokolowska J; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, QC, Canada., Stoppa-Lyonnet D; Department of Tumour Biology, Institut Curie, INSERM U830, Paris, France.; Université Paris Descartes, Paris, France., Sutter C; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany., Yen Tan Y; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria., Teixeira RM; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.; Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal., Teo SH; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.; Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia., Terry MB; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY., Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark., Tischkowitz M; Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, QC, Canada.; Department of Medical Genetics, Addenbrooke's Hospital, Cambridge, UK., Toland AE; Department of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH., Tucker KM; School of Medicine, University of New South Wales, Sydney, New South Wales, Australia.; Hereditary Cancer Centre, Prince of Wales Hospital, Sydney, New South Wales, Australia., Tung N; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA., van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands., van Engelen K; Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands., van Rensburg EJ; Department of Genetics, University of Pretoria, Arcadia, South Africa., Wang-Gohrke S; Department of Gynaecology and Obstetrics, University of Ulm, Ulm, Germany., Wappenschmidt B; Centers for Hereditary Breast and Ovarian Cancer, Integrated Oncology and Molecular Medicine, University Hospital of Cologne, Cologne, Germany Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Weitzel JN; Clinical Cancer Genetics, City of Hope, Duarte, CA., Yannoukakos D; Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece., Greene MH; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD., Rookus MA; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Easton DF; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Chenevix-Trench G; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Antoniou AC; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK., Goldgar DE; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT., Olopade OI; Department of Medicine, The University of Chicago, Chicago, IL., Rebbeck TR; Harvard T.H. Chan School of Public Health, Boston, MA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Huo D; Department of Medicine, The University of Chicago, Chicago, IL.; Department of Public Health Sciences, The University of Chicago, Chicago, IL (DH).

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2019 Apr 01; Vol. 111 (4), pp. 350-364.